DrugPatentWatch Database Preview
Roche Palo Company Profile
What is the competitive landscape for ROCHE PALO, and what generic and branded alternatives to ROCHE PALO drugs are available?
ROCHE PALO has fourteen approved drugs.
Summary for Roche Palo
| US Patents: | 0 |
| Tradenames: | 7 |
| Ingredients: | 9 |
| NDAs: | 14 |
| Patent Litigation for Roche Palo: | See patent lawsuits for Roche Palo |
Drugs and US Patents for Roche Palo
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche Palo | CELLCEPT | mycophenolate mofetil | CAPSULE;ORAL | 050722-001 | May 3, 1995 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ||||
| Roche Palo | TORADOL | ketorolac tromethamine | TABLET;ORAL | 019645-001 | Dec 20, 1991 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Roche Palo | FEMSTAT | butoconazole nitrate | CREAM;VAGINAL | 019215-001 | Nov 25, 1985 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Roche Palo | CELLCEPT | mycophenolate mofetil hydrochloride | INJECTABLE;INJECTION | 050758-001 | Aug 12, 1998 | AP | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ||||
| Roche Palo | EVEX | estrogens, esterified | TABLET;ORAL | 083376-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Roche Palo | TORADOL | ketorolac tromethamine | INJECTABLE;INJECTION | 019698-001 | Nov 30, 1989 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Roche Palo
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Roche Palo | FEMSTAT | butoconazole nitrate | CREAM;VAGINAL | 019215-001 | Nov 25, 1985 | 4,078,071 | ➤ Sign Up |
| Roche Palo | CELLCEPT | mycophenolate mofetil | SUSPENSION;ORAL | 050759-001 | Oct 1, 1998 | 4,753,935 | ➤ Sign Up |
| Roche Palo | CELLCEPT | mycophenolate mofetil hydrochloride | INJECTABLE;INJECTION | 050758-001 | Aug 12, 1998 | 4,753,935 | ➤ Sign Up |
| Roche Palo | CYTOVENE | ganciclovir sodium | INJECTABLE;INJECTION | 019661-001 | Jun 23, 1989 | 4,507,305 | ➤ Sign Up |
| Roche Palo | AEROBID | flunisolide | AEROSOL, METERED;INHALATION | 018340-001 | Aug 17, 1984 | 4,933,168 | ➤ Sign Up |
| Roche Palo | CYTOVENE | ganciclovir | CAPSULE;ORAL | 020460-001 | Dec 22, 1994 | 4,507,305 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for ROCHE PALO drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | For Oral Suspension | 200 mg/mL | ➤ Subscribe | 2011-03-25 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
